Scolaris Content Display Scolaris Content Display

D‐penicillamine for primary sclerosing cholangitis

Esta versión no es la más reciente

ver la versión actual 25 enero 2006

Referencias

Additional references

Alba 2002

Alba LM, Angulo P, Lindor KD. Primary sclerosing cholangitis. Minerva Gastroenterologica e Dietologica 2002;48(2):99‐113.

Angulo 1999

Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999;30(1):325‐32. [MEDLINE: 99315772]

Chapman 1984

Chapman RW. Primary sclerosing cholangitis. Survey of digestive diseases 1984;2:42‐51.

Chen 2003a

Chen W, Gluud C. Glucocorticosteroids for primary sclerosing cholangitis (Cochrane Review). Submitted for publication on The Cochrane Library 2004.

Chen 2003b

Chen W, Gluud C. Bile acids for primary sclerosing cholangitis (Cochrane Review). The Cochrane Library 2003, Issue 2.

DeMets 1987

DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50. [MEDLINE: 87291426]

DerSimonian 1986

DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. [MEDLINE: 87104256]

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34. [MEDLINE: 97456606]

Gluud 2001

Gluud C. Alcoholic hepatitis: no glucocorticosteroids?. In: Leuschner U, James OFW, Dancygier H editor(s). Steatohepatitis (NASH and ASH), Falk Symposium 121. Dordrecht: Kluwer Academic Publishers, 2001:322‐42.

Gross 1985

Gross JB, Ludwig J, Wiesner RH, McCall JT, LaRusso NF. Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology 1985;89(2):272‐8. [MEDLINE: 85231879]

ICH‐GCP 1997

International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines. 1. Vol. 1, PA 19063‐2043, USA: Barnett International/PAREXEL, 1997.

Kjaergard 2001

Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9. [MEDLINE: 21587469]

LaRusso 1986a

LaRusso N, Wiesner R, Ludwig J, MacCarty R, Beaver S, Zinsmeister A, et al. Randomized trial of penicillamine in primary sclerosing cholangitis [AASLD abstract]. Hepatology 1986;6(5):1205.

LaRusso 1988a

LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988;95(4):1036‐42. [MEDLINE: 88313500]

LaRusso 1999

LaRusso NF, Wiesner RH, Ludwig J. Sclerosing cholangitis. In: Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés , J editor(s). Oxford textbook of clinical hepatology. Second Edition. New York: Oxford University Press, Inc., 1999:1121‐30.

Lazaridis 1999

Lazaridis KN, Wiesner RH, Porayko MK, Ludwig J, LaRusso NF. Primary sclerosing cholangitis. In: Schiff ER, Sorrell MF, Maddrey WC editor(s). Schiff's Diseases of the Liver. Eighth. Philadelphia: Lippincott‐Raven Publishers, 1999:649‐69.

Ludwig 1990

Ludwig J, LaRusso NF, Wiesner RH. The syndrome of primary sclerosing cholangitis. Progress in Liver Diseases 1990;9:555‐66. [MEDLINE: 90193194]

Meier 2001

Meier PN, Manns MP. Medical and endoscopic treatment in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 2001;15(4):657‐66. [MEDLINE: 21384711]

Moher 1998

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13. [MEDLINE: 98417104]

Olsson 1995

Olsson R, Broome U, Danielsson A, Hagerstrand I, Jarnerot G, Loof L, et al. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995;108(4):1199‐203. [MEDLINE: 95212840]

Schulz 1995

Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12. [MEDLINE: 95123716]

Sherlock 1975

Sherlock S. Hepatolenticular degeneration. Wilson's disease. In: Sherlock S editor(s). Diseases of the liver and biliary system. Fifth. Oxford: Blackwell Scientific Publications, 1975:477‐80.

Wiesner 1980

Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79(2):200‐6. [MEDLINE: 80247340]
Table 1. Search strategies

Database

Time span

Search strategy

Cochrane Hepato‐Biliary Group Specialized Register

(Searched Nov 2002)

cholangitis AND penicillamine

The Cochrane Central Register of Controlled Trials on The Cochrane Library (Issue 4, 2002)

Issue 4, 2002 (Searched Nov 2002)

#1 CHOLANGITIS‐SCLEROSING*:ME
#2 (PRIMARY and (SCLEROSING and CHOLANGITIS))
#3 (#1 or #2)
#4 PENICILLAMINE*:ME
#5 PENICILLAMINE
#6 (#4 or #5)
#7 (#3 and #6)

EMBASE

1980 to 2002 (Searched Nov 2002)

#1 explode "primary‐sclerosing‐cholangitis"/ all subheadings
#2 explode "sclerosing‐cholangitis"/ all subheadings
#3 "primary sclerosing cholangitis"
#4 #1 or #2 or #3
#5 explode "penicillamine"/ all subheadings
#6 penicillamine
#7 #5 or #6
#8 #4 and #7
#9 #8 and random*

MEDLINE

1966 to 2002 (Searched Nov 2002)

#1 explode "Cholangitis‐Sclerosing"/ all subheadings
#2 "primary sclerosing cholangitis"
#3 #1 or #2
#4 explode "Penicillamine"/ all subheadings
#5 penicillamine
#6 #4 or #5
#7 #3 and #6
#8 #7 and (PT = "RANDOMIZED‐CONTROLLED‐TRIAL")

Figuras y tablas -
Table 1. Search strategies
Ir a la tabla del protocolo